Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Meeting Showcasing Upregulation of PD-L1 Expression with Reovirus Infection
– Oncolytic virus enhances immune checkpoint inhibitor response in prostate cancers – CALGARY, Alberta and SAN DIEGO, Nov. 09, 2018 […]